“The Therapeutic Applications Of Aptamers And Aptamer-Conjugated Nanoparticles In Cancer, Inflammatory And Viral Diseases” (2022) Journal of Pharmaceutical Negative Results, pp. 1936–1942. doi:10.47750/pnr.2022.13.S03.289.